Cerebellar and parkinsonian phenotypes in multiple system atrophy: Similarities, differences and survival

Journal of Neural Transmission

Volumn 121, Issue 5, 2014, Pages 507-512

  Roncevic, Dusan ^a   Palma, Jose Alberto ^a   Martinez, Jose ^a   Goulding, Niamh ^a   Norcliffe Kaufmann, Lucy ^a   Kaufmann, Horacio ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic; Cerebellar; MRI; MSA; MSA C; MSA P; Parkinsonism

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ARTICLE; AUTONOMIC DYSFUNCTION; AUTOPSY; CEREBELLUM DISEASE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOTOR DYSFUNCTION; MULTIPLE SYSTEM ATROPHY CEREBELLAR; MULTIPLE SYSTEM ATROPHY PARKINSONISM; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OVERALL SURVIVAL; PARKINSONISM; PATIENT COUNSELING; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHY DRAGER SYNDROME; SURVIVAL RATE; BRAIN; DRUG EFFECTS; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME;

AGE OF ONSET; ANTI-DYSKINESIA AGENTS; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; PHENOTYPE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84901332049     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1133-7     Document Type: Article

References (15)

1. Damon-Perrière N, Foubert-Samier A, De Cock VC, Gerdelat-Mas A, Debs R, Pavy-Le Traon A, Senard JM, Rascol O, Tison F, Meissner WG (2012) Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Parkinsonism Relat Disord 18(5):612-615. doi:10.1016/j.parkreldis.2011.12.009
2. Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670-676. doi:10.1212/01.wnl.0000324625.00404.15
3. Iodice V, Lipp A, Ahlskog JE et al (2012) Autopsy confirmed multiple system atrophy cases: mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 83(4):453-459. doi:10.1136/jnnp-2011-301068
4. Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ (2005) Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord 20:151-157
5. Kim HJ, Jeon BS (2012) Multiple system atrophy with prolonged survival. Mov Disord 27(14):1834. doi:10.1002/mds.25289
6. Kollensperger M, Geser F, Ndayisaba JP et al (2010) Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 25(15):2604-2612. doi:10.1002/mds.23192
7. Kraft E, Trenkwalder C, Auer DP (2002) T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 59(8):1265-1267 (Pubitemid 35192405)
8. O'Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131(Pt 5):1362-1372. doi:10.1093/brain/awn065
9. Petrovic IN, Ling H, Asi Y et al (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27(9):1186-1190. doi:10.1002/mds.25115
10. Stemberger S, Wenning GK (2011) Modelling progressive autonomic failure in MSA: where are we now? J Neural Transm 118(5):841-847. doi:10.1007/s00702- 010-0576-3
11. Tada M, Onodera O, Tada M et al (2007) Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 64(2):256-260. doi:10.1001/archneur.64.2.256
12. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 19(11):1306-1312 (Pubitemid 39534547)
13. Watanabe H, Saito Y, Terao S et al (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125(Pt 5):1070-1083 (Pubitemid 34464618)
14. Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19(12):1391-1402. doi:10.1002/mds.20255 (Pubitemid 40104046)
15. Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264-274. doi:10.1016/S1474-4422(12)70327-7